Safiullah Sarker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Safiullah Sarker has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Sharful Islam Khan
International Centre for Diarrhoeal Disease Research
6 shared publications - Masud Reza
International Centre for Diarrhoeal Disease Research
4 shared publications - Mohammed Moshtaq Pervez
Icddr,b, Bangladesh
3 shared publications Mustafizur Rahman
Virology Laboratory, Infectious Diseases Division (IDD), ICDDR,B, Dhaka, Bangladesh
3 shared publications- Mustafizur Rahman
Infectious Diseases Division, International Centre for Diarrhoeal Disease Research Bangladesh
3 shared publications A. K. M. Masud Rana
Programme for HIV and AIDS, Health Systems & Population Studies Division, International Centre for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
2 shared publications
Latest Publications
- Open Access
- 13 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342766
Prevalence and determinants of unintended pregnancy among female sex workers (FSW) in Jashore, Bangladesh
Background: Unintended pregnancy among female sex workers (FSW) is a pressing reproductive health concern attributable to risky sexual behaviors, healthcare inequities and poor negotiation powers with male sex partners. However, evidence is scarce on the prevalence and determinants of unintended pregnancies among FSW, which is crucial for enhancing reproductive healthcare. This analysis aims to measure the prevalence of lifetime unintended pregnancies and their associated factors. Methods: A cross-sectional study was conducted on 327 FSW in Jashore (a border belt district of Bangladesh) from September 2022 to March 2023. Participants were recruited through take-all sampling. Data were collected on the lifetime history of unintended pregnancies and other relevant variables through face-to-face interviews. Chi-square statistic was used to compare the characteristics of FSW reporting unintended pregnancies. To assess the net association of factors associated with unintended pregnancy, multiple logistic regression was applied. Result: The lifetime prevalence of unintended pregnancies was reported at 75.8% (95%CI: 71.0–80.1). Among those who reported unintended pregnancies, 37.1% (95%CI: 30.8–43.8) had no education, 39.9% (95%CI: 32.8–47.5) were 25–34 years old, 49.6% (95%CI: 39.3–59.9) were currently married and 62.9% (95%CI: 49.7–74.4) earned ≤10,000 BDT per month compared to those who did not report lifetime unintended pregnancies. The likelihood of unintended pregnancies was significantly higher among those who reported having sex with non-transactional male sex partners (AOR: 2.4, 95%CI: 1.1–5.3, p = 0.036) than those who never had sex with any non-transactional male sex partner. The likelihood was also higher among those who reported rape in their lifetime (AOR: 2.0, 95%CI: 1.0–3.8, p = 0.037) and who self-reported mental health problems (AOR: 2.1, 95%CI: 1.0–4.2, p = 0.045) within the past year, compared to their counterparts. Conclusion: This study highlights the considerable prevalence and associated determinants of unintended pregnancies among FSW in Jashore. These determinants need to be considered to strengthen reproductive healthcare interventions and policies for FSW. Reproductive health of FSW cannot be improved unless these factors are addressed in the ongoing interventions.
- 13 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342766
Open AccessPrevalence and determinants of unintended pregnancy among female sex workers (FSW) in Jashore, Bangladesh
Background: Unintended pregnancy among female sex workers (FSW) is a pressing reproductive health concern attributable to risky sexual behaviors, healthcare inequities and poor negotiation powers with male sex partners. However, evidence is scarce on the prevalence and determinants of unintended pregnancies among FSW, which is crucial for enhancing reproductive healthcare. This analysis aims to measure the prevalence of lifetime unintended pregnancies and their associated factors. Methods: A cross-sectional study was conducted on 327 FSW in Jashore (a border belt district of Bangladesh) from September 2022 to March 2023. Participants were recruited through take-all sampling. Data were collected on the lifetime history of unintended pregnancies and other relevant variables through face-to-face interviews. Chi-square statistic was used to compare the characteristics of FSW reporting unintended pregnancies. To assess the net association of factors associated with unintended pregnancy, multiple logistic regression was applied. Result: The lifetime prevalence of unintended pregnancies was reported at 75.8% (95%CI: 71.0–80.1). Among those who reported unintended pregnancies, 37.1% (95%CI: 30.8–43.8) had no education, 39.9% (95%CI: 32.8–47.5) were 25–34 years old, 49.6% (95%CI: 39.3–59.9) were currently married and 62.9% (95%CI: 49.7–74.4) earned ≤10,000 BDT per month compared to those who did not report lifetime unintended pregnancies. The likelihood of unintended pregnancies was significantly higher among those who reported having sex with non-transactional male sex partners (AOR: 2.4, 95%CI: 1.1–5.3, p = 0.036) than those who never had sex with any non-transactional male sex partner. The likelihood was also higher among those who reported rape in their lifetime (AOR: 2.0, 95%CI: 1.0–3.8, p = 0.037) and who self-reported mental health problems (AOR: 2.1, 95%CI: 1.0–4.2, p = 0.045) within the past year, compared to their counterparts. Conclusion: This study highlights the considerable prevalence and associated determinants of unintended pregnancies among FSW in Jashore. These determinants need to be considered to strengthen reproductive healthcare interventions and policies for FSW. Reproductive health of FSW cannot be improved unless these factors are addressed in the ongoing interventions.
- Open Access
- 28 January 2026
- Published by Springer Nature in Research Square
RSV Infection in Older Adults and Health Risks
Respiratory Syncytial Virus (RSV) remains a leading cause of respiratory illness, particularly affecting infants, older adults, and immunocompromised individuals. This article reviews the epidemiology, clinical manifestations, and current management strategies for RSV, highlighting the urgent need for effective vaccines and antiviral therapies. The study emphasizes integrating RSV vaccination into routine immunization schedules for high-risk populations and improving diagnostic capabilities. It calls for targeted public health interventions, strengthened preventive measures, and further research on vaccine optimization and novel therapeutic approaches. These steps are essential to reduce RSV-associated morbidity and mortality, ultimately improving global respiratory health.
- 28 January 2026
- Published by Springer Nature in Research Square
Open AccessRSV Infection in Older Adults and Health Risks
Respiratory Syncytial Virus (RSV) remains a leading cause of respiratory illness, particularly affecting infants, older adults, and immunocompromised individuals. This article reviews the epidemiology, clinical manifestations, and current management strategies for RSV, highlighting the urgent need for effective vaccines and antiviral therapies. The study emphasizes integrating RSV vaccination into routine immunization schedules for high-risk populations and improving diagnostic capabilities. It calls for targeted public health interventions, strengthened preventive measures, and further research on vaccine optimization and novel therapeutic approaches. These steps are essential to reduce RSV-associated morbidity and mortality, ultimately improving global respiratory health.
- Open Access
- 8 January 2026
- Published by MDPI AG in Preprints.org
Immune Landscape of Papillomavirus Infections: Innate Recognition, Adaptive Immunity, and Immune Evasion
Human papillomavirus (HPV) infection remains a major global health concern due to its strong association with cervical and other anogenital and oropharyngeal cancers. The outcome of HPV infection is largely determined by complex interactions between the virus and host immune responses. This review summarizes current knowledge on the immune landscape of HPV infection, focusing on innate immune recognition, adaptive immune responses, and viral immune evasion strategies. HPV is sensed by host pattern recognition receptors, yet it efficiently suppresses interferon signaling and cytokine responses to establish persistent infection. Adaptive immunity, including HPV-specific CD4⁺ and CD8⁺ T-cell responses and neutralizing antibodies, plays a critical role in viral clearance, while defects in these responses contribute to persistence and disease progression. The virus employs multiple immune evasion mechanisms, such as downregulation of antigen presentation and modulation of cytokine signaling, facilitating immune escape and oncogenesis. The review also highlights immune correlates of protection, vaccine-induced immunity, and emerging immunotherapeutic strategies targeting HPV-associated diseases. A comprehensive understanding of HPV–host immune interactions is essential for optimizing vaccine design, improving therapeutic interventions, and reducing the global burden of HPV-related malignancies.
- 8 January 2026
- Published by MDPI AG in Preprints.org
Open AccessImmune Landscape of Papillomavirus Infections: Innate Recognition, Adaptive Immunity, and Immune Evasion
Human papillomavirus (HPV) infection remains a major global health concern due to its strong association with cervical and other anogenital and oropharyngeal cancers. The outcome of HPV infection is largely determined by complex interactions between the virus and host immune responses. This review summarizes current knowledge on the immune landscape of HPV infection, focusing on innate immune recognition, adaptive immune responses, and viral immune evasion strategies. HPV is sensed by host pattern recognition receptors, yet it efficiently suppresses interferon signaling and cytokine responses to establish persistent infection. Adaptive immunity, including HPV-specific CD4⁺ and CD8⁺ T-cell responses and neutralizing antibodies, plays a critical role in viral clearance, while defects in these responses contribute to persistence and disease progression. The virus employs multiple immune evasion mechanisms, such as downregulation of antigen presentation and modulation of cytokine signaling, facilitating immune escape and oncogenesis. The review also highlights immune correlates of protection, vaccine-induced immunity, and emerging immunotherapeutic strategies targeting HPV-associated diseases. A comprehensive understanding of HPV–host immune interactions is essential for optimizing vaccine design, improving therapeutic interventions, and reducing the global burden of HPV-related malignancies.
- Open Access
- 4 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Whole genome sequencing of Neisseria gonorrhoeae among key populations in two cities of Bangladesh reveals genomic diversity and stable antimicrobial resistance
Neisseria gonorrhoeae is an obligate human pathogen causing gonorrhea the second most reported bacterial sexually transmitted infection. High level genomic
- 4 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessWhole genome sequencing of Neisseria gonorrhoeae among key populations in two cities of Bangladesh reveals genomic diversity and stable antimicrobial resistance
Neisseria gonorrhoeae is an obligate human pathogen causing gonorrhea the second most reported bacterial sexually transmitted infection. High level genomic
- Open Access
- 10 September 2025
- Published by Springer Nature in Research Square
Whole genome sequencing of Neisseria gonorrhoeae in two cities of Bangladesh reveals high genomic diversity and stable antimicrobial resistance among key populations
Background Neisseria gonorrhoeae is an obligate human pathogen causing gonorrhoea the second most reported bacterial sexually transmitted infection. High level genomic plasticity of this pathogen requires whole genome sequence (WGS) analysis for epidemiological investigations. The absence of N. gonorrhoeae genomic data from Bangladesh represents a critical gap in South Asian gonococcal genomic epidemiology. Here we report, a genomic investigation of N. gonorrhoeae from Bangladesh using WGS approach. Methods Twenty-four N. gonorrhoeae isolates (N = 24) were collected from key populations including female sex workers, male sex workers and hijra. These belong to two studies conducted in two districts of Bangladesh; a cross-sectional bio-behavioral survey 2014 (Dhaka) and sexual and reproductive health and rights 2022–2024 (Dhaka and Jashore). Antibiotic resistance data from disc-diffusion assay were available from specific study. Recovered isolates were sequenced using Illumina NextSeq550 instrument. Sequence typing, presence of virulence genes and antimicrobial resistance genes/mutations were determined using PubMLST, Pathogenwatch, and ABRicate. Phylogenetic analysis was conducted using Bayesian inference with globally reported selected sequences as well as WHO reference sequences. Results Genomic analysis for MLST revealed nine sequence types, with ST7363 predominating in 50% (12/24) of isolates, particularly among male sex workers (58.3%; 7/12). Phenotypic resistance was highest for ciprofloxacin (83.3%, 20/24), while all isolates remained sensitive to ceftriaxone. Novel NG-STAR types comprised 33.3% (8/24) of isolates, while novel NG-MAST types reached 62.5% (15/24). Genomic analysis predicted resistance to ciprofloxacin (100%), sulfonamides (91.7%) and tetracycline (79.2%), while 100% sensitivity was predicted for azithromycin, ceftriaxone and spectinomycin. Phylogenetic analysis showed four intra clusters for 18 isolates and 6 were distributed separately. Conclusions Here we report, high genomic diversity of N. gonorrhoeae from, however relatively stable antibiotic susceptibility pattern in comparison to previous studies. These findings emphasize the urgent need for genomic surveillance and antimicrobial stewardship in Bangladesh to preserve current treatment options.
- 10 September 2025
- Published by Springer Nature in Research Square
Open AccessWhole genome sequencing of Neisseria gonorrhoeae in two cities of Bangladesh reveals high genomic diversity and stable antimicrobial resistance among key populations
Background Neisseria gonorrhoeae is an obligate human pathogen causing gonorrhoea the second most reported bacterial sexually transmitted infection. High level genomic plasticity of this pathogen requires whole genome sequence (WGS) analysis for epidemiological investigations. The absence of N. gonorrhoeae genomic data from Bangladesh represents a critical gap in South Asian gonococcal genomic epidemiology. Here we report, a genomic investigation of N. gonorrhoeae from Bangladesh using WGS approach. Methods Twenty-four N. gonorrhoeae isolates (N = 24) were collected from key populations including female sex workers, male sex workers and hijra. These belong to two studies conducted in two districts of Bangladesh; a cross-sectional bio-behavioral survey 2014 (Dhaka) and sexual and reproductive health and rights 2022–2024 (Dhaka and Jashore). Antibiotic resistance data from disc-diffusion assay were available from specific study. Recovered isolates were sequenced using Illumina NextSeq550 instrument. Sequence typing, presence of virulence genes and antimicrobial resistance genes/mutations were determined using PubMLST, Pathogenwatch, and ABRicate. Phylogenetic analysis was conducted using Bayesian inference with globally reported selected sequences as well as WHO reference sequences. Results Genomic analysis for MLST revealed nine sequence types, with ST7363 predominating in 50% (12/24) of isolates, particularly among male sex workers (58.3%; 7/12). Phenotypic resistance was highest for ciprofloxacin (83.3%, 20/24), while all isolates remained sensitive to ceftriaxone. Novel NG-STAR types comprised 33.3% (8/24) of isolates, while novel NG-MAST types reached 62.5% (15/24). Genomic analysis predicted resistance to ciprofloxacin (100%), sulfonamides (91.7%) and tetracycline (79.2%), while 100% sensitivity was predicted for azithromycin, ceftriaxone and spectinomycin. Phylogenetic analysis showed four intra clusters for 18 isolates and 6 were distributed separately. Conclusions Here we report, high genomic diversity of N. gonorrhoeae from, however relatively stable antibiotic susceptibility pattern in comparison to previous studies. These findings emphasize the urgent need for genomic surveillance and antimicrobial stewardship in Bangladesh to preserve current treatment options.
- Open Access
- 6 July 2025
- Published by SAGE Publications in Cancer Control
- Vol. 32
From Bench to Bedside in Emerging Therapies for Gynecological Malignancies: A Narrative Review
Gynecological malignancies, including cervical, endometrial, and ovarian cancers, pose significant global health challenges due to their increasing incidence and limitations in conventional treatments. Current therapeutic approaches, such as surgery, chemotherapy, and radiation, often face obstacles like multidrug resistance, tumor recurrence, and adverse side effects. In response, emerging therapies—including targeted therapy, immunotherapy, and gene therapy—are reshaping treatment paradigms. Precision medicine, leveraging Poly ADP-ribose Polymerase (PARP) and Vascular Endothelial Growth Factor (VEGF) inhibitors, enhances therapeutic efficacy, while immune checkpoint inhibitors and vaccine-based therapies offer promising immunotherapeutic strategies. Additionally, advancements in nanotechnology and gene therapy, including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) based approaches and nanoparticle-mediated drug delivery, provide novel treatment modalities. Despite these innovations, translational challenges persist, necessitating further research into clinical applications and personalized treatment strategies. This review highlights the latest advancements in emerging therapies for gynecological malignancies, emphasizing their potential to improve patient outcomes and address existing treatment limitations.
- 6 July 2025
- Published by SAGE Publications in Cancer Control
- Vol. 32
Open AccessFrom Bench to Bedside in Emerging Therapies for Gynecological Malignancies: A Narrative Review
Gynecological malignancies, including cervical, endometrial, and ovarian cancers, pose significant global health challenges due to their increasing incidence and limitations in conventional treatments. Current therapeutic approaches, such as surgery, chemotherapy, and radiation, often face obstacles like multidrug resistance, tumor recurrence, and adverse side effects. In response, emerging therapies—including targeted therapy, immunotherapy, and gene therapy—are reshaping treatment paradigms. Precision medicine, leveraging Poly ADP-ribose Polymerase (PARP) and Vascular Endothelial Growth Factor (VEGF) inhibitors, enhances therapeutic efficacy, while immune checkpoint inhibitors and vaccine-based therapies offer promising immunotherapeutic strategies. Additionally, advancements in nanotechnology and gene therapy, including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) based approaches and nanoparticle-mediated drug delivery, provide novel treatment modalities. Despite these innovations, translational challenges persist, necessitating further research into clinical applications and personalized treatment strategies. This review highlights the latest advancements in emerging therapies for gynecological malignancies, emphasizing their potential to improve patient outcomes and address existing treatment limitations.
- Open Access
- 12 April 2025
- Published by Wiley
RSV Infection in Older Adults and Health Risks
Respiratory Syncytial Virus (RSV) remains a leading cause of respiratory illness, particularly affecting infants, older adults, and immunocompromised individuals. This article reviews the epidemiology, clinical manifestations, and current management strategies for RSV, highlighting the urgent need for effective vaccines and antiviral therapies. The study emphasizes integrating RSV vaccination into routine immunization schedules for high-risk populations and improving diagnostic capabilities. It calls for targeted public health interventions, strengthened preventive measures, and further research on vaccine optimization and novel therapeutic approaches. These steps are essential to reduce RSV-associated morbidity and mortality, ultimately improving global respiratory health.
- 12 April 2025
- Published by Wiley
Open AccessRSV Infection in Older Adults and Health Risks
Respiratory Syncytial Virus (RSV) remains a leading cause of respiratory illness, particularly affecting infants, older adults, and immunocompromised individuals. This article reviews the epidemiology, clinical manifestations, and current management strategies for RSV, highlighting the urgent need for effective vaccines and antiviral therapies. The study emphasizes integrating RSV vaccination into routine immunization schedules for high-risk populations and improving diagnostic capabilities. It calls for targeted public health interventions, strengthened preventive measures, and further research on vaccine optimization and novel therapeutic approaches. These steps are essential to reduce RSV-associated morbidity and mortality, ultimately improving global respiratory health.
- Open Access
- 25 March 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Virology
- Vol. 14 (1) , 100160
Rhabdomyolysis-related acute kidney injury in COVID-19: A critical concern
Rhabdomyolysis is a severe condition characterized by the breakdown of muscle tissue leading to the release of intracellular components into the bloodstream. This condition, when associated with acute kidney injury (AKI), can result in significant morbidity and mortality, particularly in the context of coronavirus disease 2019 (COVID-19). This editorial discusses a retrospective study on patients with COVID-19 who developed rhabdomyolysis-related AKI. The study highlights that patients with rhabdomyolysis exhibited higher inflammatory markers, such as C-reactive protein, ferritin, and procalcitonin, and experienced worse clinical outcomes compared to those with other causes of AKI. The findings underscore the importance of early recognition and management of rhabdomyolysis in COVID-19 patients to improve prognosis and reduce mortality rates.
- 25 March 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Virology
- Vol. 14 (1) , 100160
Open AccessRhabdomyolysis-related acute kidney injury in COVID-19: A critical concern
Rhabdomyolysis is a severe condition characterized by the breakdown of muscle tissue leading to the release of intracellular components into the bloodstream. This condition, when associated with acute kidney injury (AKI), can result in significant morbidity and mortality, particularly in the context of coronavirus disease 2019 (COVID-19). This editorial discusses a retrospective study on patients with COVID-19 who developed rhabdomyolysis-related AKI. The study highlights that patients with rhabdomyolysis exhibited higher inflammatory markers, such as C-reactive protein, ferritin, and procalcitonin, and experienced worse clinical outcomes compared to those with other causes of AKI. The findings underscore the importance of early recognition and management of rhabdomyolysis in COVID-19 patients to improve prognosis and reduce mortality rates.
- Open Access
- 28 February 2025
- Published by MDPI AG in Preprints.org
Selenium as a Nutritional Shield in Viral Defense: A Narrative Review
Selenium, an essential micronutrient, plays a critical role in immune function, oxidative stress regulation, and antiviral defense. This review highlights selenium’s diverse biological functions, its role in reducing oxidative stress, and its impact on immune modulation. Studies have shown that selenium enhances immune response, mitigates inflammation, and supports antiviral properties. Its deficiency is associated with increased susceptibility to viral infections, including HIV and COVID-19. The potential of selenium as a therapeutic agent in managing viral diseases and improving immune responses is discussed, emphasizing its significance in public health, particularly in selenium-deficient regions.
- 28 February 2025
- Published by MDPI AG in Preprints.org
Open AccessSelenium as a Nutritional Shield in Viral Defense: A Narrative Review
Selenium, an essential micronutrient, plays a critical role in immune function, oxidative stress regulation, and antiviral defense. This review highlights selenium’s diverse biological functions, its role in reducing oxidative stress, and its impact on immune modulation. Studies have shown that selenium enhances immune response, mitigates inflammation, and supports antiviral properties. Its deficiency is associated with increased susceptibility to viral infections, including HIV and COVID-19. The potential of selenium as a therapeutic agent in managing viral diseases and improving immune responses is discussed, emphasizing its significance in public health, particularly in selenium-deficient regions.
- Open Access
- 15 January 2025
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 68 (1) , 30-42
Decoding impact of human papillomavirus in gynecological oncology: a narrative review
Human papillomavirus (HPV) is a key factor in gynecological oncology. This narrative review investigates the complex connection between HPV and various gynecological cancers. For a comprehensive exploration, we examined the association between persistent HPV infection and cervical cancer and its global prevalence. Beyond the cervix, we navigated the linkages between HPV and other gynecological malignancies, shedding light on vulvar, vaginal, anal, and oropharyngeal cancers. The narrative extends to discuss the critical role of HPV vaccination in preventing these cancers and exploring challenges, controversies, and future perspectives in the field. As we have described the impact of HPV, this review underscores the significance of ongoing research and public health endeavors in shaping the trajectory of gynecological oncology.
- 15 January 2025
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 68 (1) , 30-42
Open AccessDecoding impact of human papillomavirus in gynecological oncology: a narrative review
Human papillomavirus (HPV) is a key factor in gynecological oncology. This narrative review investigates the complex connection between HPV and various gynecological cancers. For a comprehensive exploration, we examined the association between persistent HPV infection and cervical cancer and its global prevalence. Beyond the cervix, we navigated the linkages between HPV and other gynecological malignancies, shedding light on vulvar, vaginal, anal, and oropharyngeal cancers. The narrative extends to discuss the critical role of HPV vaccination in preventing these cancers and exploring challenges, controversies, and future perspectives in the field. As we have described the impact of HPV, this review underscores the significance of ongoing research and public health endeavors in shaping the trajectory of gynecological oncology.